Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trinity Biotech (TRIB) Income towards Parent Company (2016 - 2024)

Trinity Biotech's Income towards Parent Company history spans 16 years, with the latest figure at -$15.8 million for Q4 2024.

  • On a quarterly basis, Income towards Parent Company fell 193.08% to -$15.8 million in Q4 2024 year-over-year; TTM through Dec 2025 was -$20.6 million, a 32.85% increase, with the full-year FY2025 number at -$37.4 million, down 17.58% from a year prior.
  • Income towards Parent Company hit -$15.8 million in Q4 2024 for Trinity Biotech, down from -$4.8 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for TRIB hit a ceiling of $10.7 million in Q3 2020 and a floor of -$18.3 million in Q2 2023.
  • Historically, Income towards Parent Company has averaged -$3.6 million across 5 years, with a median of -$4.1 million in 2021.
  • Biggest five-year swings in Income towards Parent Company: skyrocketed 511.27% in 2020 and later crashed 188690.44% in 2023.
  • Tracing TRIB's Income towards Parent Company over 5 years: stood at $10.4 million in 2020, then tumbled by 132.48% to -$3.4 million in 2021, then tumbled by 210.31% to -$10.4 million in 2022, then soared by 48.38% to -$5.4 million in 2023, then crashed by 193.08% to -$15.8 million in 2024.
  • Business Quant data shows Income towards Parent Company for TRIB at -$15.8 million in Q4 2024, -$4.8 million in Q3 2024, and -$6.9 million in Q2 2024.